Evaluation of soluble P‐selectin as a predictive biomarker in acute symptomatic pulmonary embolism: Insights from a prospective observational study
CM Oblitas, P Demelo‐Rodríguez… - European Journal of …, 2024 - Wiley Online Library
Abstract Background Soluble P‐selectin (sP‐selectin) has been proposed as a potential
biomarker for venous thromboembolism (VTE) diagnosis with interesting results. However …
biomarker for venous thromboembolism (VTE) diagnosis with interesting results. However …
High levels of soluble P-selectin, neutrophil extracellular traps, and myeloperoxidase as risk factor of deep vein thrombosis in malignancy patients receiving platinum …
Backgrounds Venous Thromboembolism (VTE) is a disease entity comprising Deep Vein
Thrombosis (DVT) and Pulmonary Embolism (PE). VTE events increase the mortality rate of …
Thrombosis (DVT) and Pulmonary Embolism (PE). VTE events increase the mortality rate of …
Pathogenesis and new insights into acute and chronic venous thrombosis
AT Obi, PK Henke, TW Wakefield - Handbook of Venous and …, 2024 - taylorfrancis.com
Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and
pulmonary embolism (PE), may affect up to 900,000 patients per year, resulting in …
pulmonary embolism (PE), may affect up to 900,000 patients per year, resulting in …
[引用][C] Duración del tratamiento anticoagulante en la Enfermedad Tromboembólica Venosa asociada al cáncer
A Solier-López - 2024